A Combination of Moringin and Avenanthramide 2f Inhibits the Proliferation of Hep3B Liver Cancer Cells Inducing Intrinsic and Extrinsic Apoptosis

References

• Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3, 768–780, 2003.
   PubMed Web of Science ®Google Scholar
• Cairns RA, Harris IS, and Mak TW: Regulation of cancer cell metabolism. Nat Rev Cancer 11, 85–95, 2011.
   PubMed Web of Science ®Google Scholar
• Reed JC: Apoptosis-based therapies. Nat Rev Drug Discov 1, 111–121, 2002.
   PubMed Web of Science ®Google Scholar
• Puccini J, Dorstyn L, and Kumar S: Caspase-2 as a tumour suppressor. Cell Death Differ 20, 1133–1139, 2013.
   PubMed Web of Science ®Google Scholar
• Samali A and Jager R: Mechanisms of resistance to cell death pathways in cancer cells. In: Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms, 1st ed., McManus LM and Mitchell RN (eds.). Amsterdam, NL: Elsevier Inc., 2014, pp. 393–402.
   Google Scholar
• Matt S and Hofmann TG: The DNA damage-induced cell death response: A roadmap to kill cancer cells. Cell Mol Life Sci 73, 2829–2850, 2016.
   PubMed Web of Science ®Google Scholar
• Altieri DC: Targeting survivin in cancer. Cancer Lett 332, 225–228, 2013.
   PubMed Web of Science ®Google Scholar
• Scarpa ES, Antonini E, Palma F, Mari M, and Ninfali P: Antiproliferative activity of vitexin-2-O-xyloside and avenanthramides on CaCo-2 and HepG2 cancer cells occurs through apoptosis induction and reduction of pro-survival mechanisms. Eur J Nutr 57, 1381–1395, 2018.
   PubMed Web of Science ®Google Scholar
• Farabegoli F, Scarpa ES, Frati A, Serafini G, Papi A, et al.: Betalains increase vitexin-2-O-xyloside cytotoxicity in CaCo-2 cancer cells. Food Chem 218, 356–364, 2017.
   PubMed Web of Science ®Google Scholar
• Anwar F, Latif S, Ashraf M, and Gilani AH: Moringa oleifera: a food plant with multiple medicinal uses. Phytother Res 21, 17–25, 2007.
   PubMed Web of Science ®Google Scholar
• Biswas SK, Chowdhury A, Das J, Roy A, and Zahid HSM. Pharmacological potentials of Moringa oleifera Lam.: A review. Int J Pharm Sci Res 47, 305–310, 2012.
   Google Scholar
• Muller C, van LJ, Ruschioni S, De Nicola GR, Olsen CE, et al.: Taste detection of the non-volatile isothiocyanate moringin results in deterrence to glucosinolate-adapted insect larvae. Phytochemistry 118, 139–148, 2015.
   PubMed Web of Science ®Google Scholar
• Rajan TS, De Nicola GR, Iori R, Rollin P, Bramanti P, et al.: Anticancer activity of glucomoringin isothiocyanate in human malignant astrocytoma cells. Fitoterapia 110, 1–7, 2016.
   PubMed Web of Science ®Google Scholar
• Brunelli D, Tavecchio M, Falcioni C, Frapolli R, Erba E, et al.: The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo. Biochem Pharmacol 79, 1141–1148, 2010.
   PubMed Web of Science ®Google Scholar
• Giacoppo S, Iori R, Rollin P, Bramanti P, and Mazzon E: Moringa isothiocyanate complexed with α-cyclodextrin: a new perspective in neuroblastoma treatment. BMC Complement Altern Med 17, 362–371, 2017.
   PubMed Web of Science ®Google Scholar
• Peterson DM: Oat antioxidants. J Cereal Sci 33, 115–129, 2001.
   Web of Science ®Google Scholar
• Collins FW: Oat phenolics: Avenanthramides, novel substituted N-cinnamoylanthranilate alkaloids from oat groats and hulls. J Agric Food Chem 37, 60–66, 1989.
   Web of Science ®Google Scholar
• Chen CYO, Milbury PE, Collins FW, and Blumberg JB: Avenanthramides are bioavailable and have antioxidant activity in humans after acute consumption of an enriched mixture from oats. J Nutr 137, 1375–1382, 2007.
   PubMed Web of Science ®Google Scholar
• Meydani M: Potential health benefits of avenanthramides of oats. Nutr Rev 67, 731–735, 2009.
   PubMed Web of Science ®Google Scholar
• Guo WM, Nie L, Wu DY, Wise ML, Collins FW, et al.: Avenanthramides inhibit proliferation of human colon cancer cell lines in vitro. Nutr Cancer 62, 1007–1016, 2010.
   PubMed Web of Science ®Google Scholar
• Danko B, Martins A, Chuang DW, Wang HC, Amaral L, et al.: In vitro cytotoxic activity of novel protoflavone analogs GÇô selectivity towards a multidrug resistant cancer cell line. Anticancer Res 32, 2863–2869, 2012.
   PubMed Web of Science ®Google Scholar
• Ninfali P, Gennari L, Biagiotti E, Cangi F, Mattoli L, et al.: Improvement in botanical standardization of commercial freeze-dried herbal extracts by using the combination of antioxidant capacity and constituent marker concentrations. J AOAC Int 92, 797–805, 2009.
   PubMed Web of Science ®Google Scholar
• Michl C, Vivarelli F, Weigl J, De Nicola GR, Canistro D, et al.: The chemopreventive phytochemical moringin isolated from Moringa oleifera seeds inhibits JAK/STAT signaling. PLoS One 11, e0157430, 2016.
   PubMed Web of Science ®Google Scholar
• Blasa M, Angelino D, Gennari L, and Ninfali P: The cellular antioxidant activity in red blood cells (CAA-RBC): a new approach to bioavailability and synergy of phytochemicals and botanical extracts. Food Chem 125, 685–691, 2011.
   Web of Science ®Google Scholar
• Johnson ME and Howerth EW: Survivin: a bifunctional inhibitor of apoptosis protein. Vet Pathol 41, 599–607, 2004.
   PubMed Web of Science ®Google Scholar
• Harris IS and Brugge JS: Cancer: The enemy of my enemy is my friend. Nature 527, 170–171, 2015.
   PubMed Web of Science ®Google Scholar
• Wang D, Wise ML, Li F, and Dey M: Phytochemicals attenuating aberrant activation of β-catenin in cancer cells. PLoS One 7, e50508, 2012.
   PubMed Web of Science ®Google Scholar
• Hastings J and Kenealey J: Chemotherapeutic effects of avenanthramides on breast cancer cells. FASEB J 31, 790–805, 2017.
   Web of Science ®Google Scholar
• Scarpa ES, Mari M, Antonini E, Palma F, and Ninfali P: Natural and synthetic avenanthramides activate caspases 2, 8, 3 and downregulate hTERT, MDR1 and COX-2 genes in CaCo-2 and Hep3B cancer cells. Food Funct 9, 2913–2921, 2018.
   PubMed Web of Science ®Google Scholar